Engaging Nursing Students in a Culture of Integrity
Creator:
Gaviola, Melissa S. and Moore, Holly A.
Related Url Tesim:
Full text available from the library catalog: https://marianunivindianapolis.on.worldcat.org/v2/oclc/7428972794 and Available via PubMed: https://pubmed.ncbi.nlm.nih.gov/29614194/
Description:
Background: In order to become safe, effective professionals, nursing students must have a working knowledge of academic and professional integrity principles. However, nursing students have knowledge gaps in these areas, which may lead to unethical practices postgraduation. Inconsistencies in faculty enforcement of integrity principles may lead to student confusion and further student risk.
Method: An interactive online integrity course was designed to address knowledge gaps related to academic and professional integrity. Course engagement occurred through self-reflection, quizzes, and a commitment statement. The pilot course was deployed to all nursing faculty and staff for feedback and approval.
Results: Of the 38 faculty and staff invited, 20 participated in the course. Based on feedback, course adjustments were made to address navigation, quiz clarity, and content. The online integrity course received full faculty approval.
Conclusion: An interactive online integrity course is one option to support student engagement in and assimilation to a culture of integrity.
Subject:
Nursing Education Research , Ethics, Nursing / education* , and Students, Nursing / psychology*
Rights statement:
http://rightsstatements.org/vocab/InC/1.0/
Language:
English
Publisher:
SLACK Incorporated
Identifier:
DOI: 10.3928/01484834-20180322-09 and PMID: 29614194
Type:
Article
Keyword:
faculty enforcement , interactive online integrity course, academic and professional integrity principles, and knowledge gaps
The Metabolic Bone Disease X-linked Hypophosphatemia: Case Presentation, Pathophysiology and Pharmacology
Creator:
Vincze, Jon, Hum, Julia, Conaway, Kory, Skinner, Brian, Tucker, Katherine, and Lowery, Jonathan
Related Url Tesim:
Available from the publisher: https://www.mdpi.com/2075-1729/11/6/563 and Available from PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232744/
Description:
The authors present a stereotypical case presentation of X-linked hypophosphatemia (XLH) and provide a review of the pathophysiology and related pharmacology of this condition, primarily focusing on the FDA-approved medication burosumab. XLH is a renal phosphate wasting disorder caused by loss of function mutations in the PHEX gene (phosphate-regulating gene with homologies to endopeptidases on the X chromosome). Typical biochemical findings include elevated serum levels of bioactive/intact fibroblast growth factor 23 (FGF23) which lead to (i) low serum phosphate levels, (ii) increased fractional excretion of phosphate, and (iii) inappropriately low or normal 1,25-dihydroxyvitamin D (1,25-vitD). XLH is the most common form of heritable rickets and short stature in patients with XLH is due to chronic hypophosphatemia. Additionally, patients with XLH experience joint pain and osteoarthritis from skeletal deformities, fractures, enthesopathy, spinal stenosis, and hearing loss. Historically, treatment for XLH was limited to oral phosphate supplementation, active vitamin D supplementation, and surgical intervention for cases of severe bowed legs. In 2018, the United States Food and Drug Administration (FDA) approved burosumab for the treatment of XLH and this medication has demonstrated substantial benefit compared with conventional therapy. Burosumab binds circulating intact FGF23 and blocks its biological effects in target tissues, resulting in increased serum inorganic phosphate (Pi) concentrations and increased conversion of inactive vitamin D to active 1,25-vitD.
Rights statement:
http://rightsstatements.org/vocab/InC/1.0/
Language:
English
Publisher:
MDPI
Identifier:
PMID: 34203792 and DOI: 10.3390/life11060563
Type:
Article
Keyword:
burosumab, Crysvita®, KRN23, metabolic bone disease, and X-linked hypophosphatemia
Systematic Review to Develop the Clinical Practice Guideline for the Use of Capnography During Procedural Sedation in Radiology and Imaging Settings: A Report of the Association for Radiologic & Imaging Nursing Capnography Task Force
Creator:
Shawn Brast, Mary Sousa, Barbara McArthur, Marisol Hernandez, Christopher Lambert, Carissa West, Karen Green, Michael Long (Marian University), and Lisa Pella
Advances in radiology and imaging technologies and the emergent scope of practice have led to the capacity to provide services to a growing population of high-acuity patients with comorbid conditions. These procedures are often performed with the radiology nurse administering procedural sedation. Monitoring patients is challenging due to certain patient conditions and the unique environment, that is, the radiology procedure suite. The addition of capnography monitoring, along with standard monitoring, is a valuable modality that provides a continuous objective assessment of the patient's ventilatory status even when direct visualization of the patient is compromised. The purpose of this article is to provide clinical practice recommendations for the use of capnography by procedural sedation nurses outside the operating room setting.
Rights statement:
http://rightsstatements.org/vocab/InC/1.0/
Language:
English
Publisher:
Association for Radiologic & Imaging Nursing. Published by Elsevier Inc.
Identifier:
10.1016/j.jradnu.2018.07.003
Type:
Article
Keyword:
Procedural sedation, Capnography , Radiology nurse, Ventilation, and Nursing